Background/Aims: Elevated plasma total homocysteine (tHcy) concentrations are a risk factor for neural tube defects and vascular diseases. Supplementation with folic acid decreases tHcy. We investigated whether supplementation with 500 µg folic acid every other day is as effective in lowering tHcy as 250 µg folic acid each day. Methods: In a 4-week intervention study, 22 healthy young women (18–40 years old) took either 500 µg folic acid every other day (500-µg/2d group) or 250 µg folic acid each day (250-µg/d group). Fasting blood was collected on days 0 and 28. Results: Plasma folate concentrations increased by 11.4 nmol/l (6.8–15.9) in the 250-µg/d group and by 9.1 nmol/l (95% Cl 1.9–16.3) in the 500-µg/2d group. These increases were not significantly different from each other. THcy concentrations decreased by 1.52 µmol/l (95% Cl –2.09 to –0.95; p < 0.001) in the 250-µg/d group and by 0.88 µmol/l (–1.53 to –0.23; p < 0.05) in the 500-µg/2d group. The difference in decrease between the 250-µg/d group and the 500-µg/2d group was 0.64 µmol/l (p = 0.11). Conclusion: Although not conclusive, this study suggests that supplying subjects with folic acid each day decreases tHcy more effectively than a double dose every other day.

Keywords:
Folic acid, Folate, Homocysteine, Women
This content is only available via PDF.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.